Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 14/20 | 0.72 |
| ▸ | RAB9A | P51151 | 14/20 | 0.72 |
| ▸ | SMN1; SMN2 | Q16637 | 11/20 | 0.72 |
| ▸ | HPGD | P15428 | 6/20 | 0.72 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.72 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.72 |
| ▸ | RELA | Q04206 | 2/20 | 0.72 |
| ▸ | POLB | P06746 | 2/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.60 |
| ▸ | TSHR | P16473 | 2/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.55 |
| ▸ | MAPT | P10636 | 3/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13134518 | 0.95 | NPC1 (0.77) | NPC1RAB9ASMN1; SMN2HPGDNFKB1 | |
| SCHEMBL13134571 | 0.87 | NPC1 (0.65) | NPC1RAB9ASMN1; SMN2HPGDNFKB1 | |
| SCHEMBL13134523 | 0.87 | NPC1 (0.65) | NPC1RAB9ASMN1; SMN2HPGDNFKB1 | |
| SCHEMBL13134524 | 0.87 | NPC1 (0.65) | NPC1RAB9ASMN1; SMN2HPGDNFKB1 | |
| SCHEMBL13134570 | 0.86 | NPC1 (0.71) | NPC1RAB9ASMN1; SMN2HPGDNFKB1 | |
| SCHEMBL2813678 | 0.86 | NPC1 (0.71) | NPC1RAB9ASMN1; SMN2HPGDNFKB1 | |
| SCHEMBL17125514 | 0.85 | NPC1 (0.52) | NPC1RAB9ASMN1; SMN2HPGDNFKB1 | |
| SCHEMBL13134527 | 0.85 | NPC1 (0.68) | NPC1RAB9ASMN1; SMN2HPGDNFKB1 | |
| SCHEMBL13134576 | 0.85 | NPC1 (0.68) | NPC1RAB9ASMN1; SMN2HPGDNFKB1 | |
| SCHEMBL13134516 | 0.85 | NPC1 (0.68) | NPC1RAB9ASMN1; SMN2HPGDNFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8481176-B2 | Oxadiazole derivative, and light-emitting element, light-emitting device, electronic device, and lighting device using oxadiazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-07-09 | — | — | US | disclosed |
| US-8481176-B2 | Oxadiazole derivative, and light-emitting element, light-emitting device, electronic device, and lighting device using oxadiazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-07-09 | — | — | US | disclosed |
| US-20100244673-A1 | Oxadiazole Derivative, and Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device Using Oxadiazole Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2010-09-30 | — | — | US | disclosed |
| US-20100244673-A1 | Oxadiazole Derivative, and Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device Using Oxadiazole Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2010-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100244673-A1 | Oxadiazole Derivative, and Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device Using Oxadiazole Derivative | OXA1L, OXER1, DRD1 | NPC1 2559/4885RAB9A 3017/4885SMN1; SMN2 3013/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.